Follow-on roundup: Acadia raises $275M, Rocket pockets $55M

Follow-on roundup: Acadia raises $275M, Rocket pockets $55M

Source: 
BioCentury
snippet: 

CNS company Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) and gene therapy company Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) each priced follow-ons late Tuesday, raising $275 million and $55 million, respectively.